In a research paper published on Dec. 4 in the Journal of the American Medical Association (JAMA) Network Open, which summarized a study of 30 million French citizens, the French epidemiological group Epi-Phare summed up its findings: “Messenger RNA [mRNA] vaccines against Covid-19 do not increase the long-term risk of death from any cause,” Le Monde reported on Dec. 5.
The team assessed data from 28 million adults, ages 18 to 59, between 2021 and 2025. Around 23 million received at least one vaccine dose from mid-2021 onwards, when France launched its mass vaccination campaign against the virus. The remaining 6 million have not been vaccinated, Le Monde stated.
